AI.VS.CLINICIAN: UNVEILING INTRICATE INTERACTIONS BETWEEN
AI AND CLINICIANS THROUGH AN OPEN-ACCESS DATABASE
EDITEDBY
WANLINGGAO
YUANLIU
ZHUOMINGYU
DANDANCUI
WENJINGLIU
XIAOSHUANGLIANG
JIAHUIZHAO
JIYUEXIE
HAOLI
LIMA
NINGYE
YUMIAOKANG
DINGFENGLUO
PENGPAN
WEIHUANG
ZHONGMOULIU
JIZHONGHU
FANHUANG
GANGYUANZHAO
CHONGRONGJIANG
TIANYIWEI
ZHIFEIZHANG
YUNYOUHUANG
JIANFENGZHAN
BenchCouncil: InternationalOpenBenchmarkCouncil
http://www.benchcouncil.org
TECHNICALREPORTNO. BENCHCOUNCIL-AI.VS.CLINICIAN-2024
JUNE 11, 2024
4202
nuJ
11
]CH.sc[
1v26370.6042:viXraAI.vs.Clinician: Unveiling Intricate Interactions
Between AI and Clinicians through an Open-Access
Database
Wanling Gao1,3,4,†, Yuan Liu5,†, Zhuoming Yu2,18, Dandan Cui1, Wenjing Liu5, Xiaoshuang
Liang2,18, Jiahui Zhao2,18, Jiyue Xie2,18, Hao Li2,18, Li Ma5,9, Ning Ye6, Yumiao Kang6,
Dingfeng Luo7, Peng Pan8, Wei Huang10, Zhongmou Liu11, Jizhong Hu12, Fan Huang13,
Gangyuan Zhao14, Chongrong Jiang15, Tianyi Wei16, Zhifei Zhang17,*, Yunyou Huang2,18,*,
and Jianfeng Zhan1,3,4,*
1InstituteofComputingTechnology,ChineseAcademyofSciences,Beijing,100190,China
2GuangxiKeyLabofMulti-SourceInformationMiningandSecurity,GuangxiNormalUniversity,Guilin,541004,
China
3InternationalOpenBenchmarkCouncil
4UniversityofChineseAcademyofSciences,Beijing,100086,China
5GuilinMedicalUniversity,Guilin,541100,China
6AffiliatedHospitalofGuilinMedicalUniversity,Guilin,541000,China
7XingAnCountyPeople’sHospital,Guilin,541300,China
8MengShanCountyPeople’sHospital,Wuzhou,543000,China
9XuanJiTechnologyCo.,Ltd.,Guilin,541000,China
10GuilinPeople’sHospital,Guilin,541000,China
11YongFuCountyPeople’sHospital,Guilin,541000,China
12LingChuanCountyPeople’sHospital,Guilin,541000,China
13TheSecondAffiliatedHospitalofGuilinMedicalUniversity,Guilin,541000,China
14QuanZhouCountyPeople’sHospital,Guilin,541000,China
15GuanYangCountyPeople’sHospital,Guilin,541000,China
16InternationalCollege,GuangxiUniversity,Nanning,530004,China
17CapitalMedicalUniversity,Beijing,100069,China
18KeyLabofEducationBlockchainandIntelligentTechnology,MinistryofEducation,GuangxiNormalUniversity,
Guilin,541004,China
†co-firstauthor
*correspondingauthor(s): JianfengZhan(zhanjianfeng@ict.ac.cn)andYunyouHuang
(huangyunyou@gxnu.edu.cn)andZhifeiZhang(zhifeiz@ccmu.edu.cn)
ABSTRACT
ArtificialIntelligence(AI)playsacrucialroleinmedicalfieldandhasthepotentialtorevolutionizehealthcarepractices. However,
thesuccessofAImodelsandtheirimpactshingeonthesynergybetweenAIandmedicalspecialists,withcliniciansassuming
adominantrole. Unfortunately,theintricatedynamicsandinteractionsbetweenAIandcliniciansremainundiscoveredandthus
hinderAIfrombeingtranslatedintomedicalpractice. Toaddressthisgap,wehavecuratedagroundbreakingdatabasecalled
AI.vs.Clinician. ThisdatabaseisthefirstofitskindforstudyingtheinteractionsbetweenAIandclinicians. Itderivesfrom7,500
collaborativediagnosisrecordsonalife-threateningmedicalemergency–Sepsis–from14medicalcentersacrossChina.
Forthepatientcohortswell-chosenfromMIMICdatabases,theAI-relatedinformationcomprisesthemodelproperty,feature
input,diagnosisdecision,andinferredprobabilitiesofsepsisonsetpresentlyandwithinnextthreehours. Theclinician-related
informationincludestheviewedexaminationdataandsequence,viewedtime,preliminaryandfinaldiagnosisdecisionswithor
withoutAIassistance,andrecommendedtreatment.
Background & Summary
ArtificialIntelligence(AI),asarevolutionarytechnology, hasattractedextensiveresearchonitsapplicationstomedicine,
leadingtotheemergenceofanewresearchfieldknownasAIinmedicine1–5. Despitethisadvance,integratingAImodelsintoreal-worldmedicalsystemsandclinicalpracticeisstillfaraway. Onesignificantreasonisthatcliniciansstillplayimportant
roles6andreflectunknownmeanwhileunpredictableinteractionswithAI2.Meanwhile,human-in-the-loopisconsideredan
essentialdevelopmentaltrendofAIinmedicineandisgraduallygainingattention7–11. However,thelackofopen,accessible
interactiondatabetweenAIandcliniciansposessignificantchallengestorelatedresearch. IthindersAIimprovementsthatcan
betterassistcliniciansinclinicalpractice.
Collaboratedwith14medicalcentersand125cliniciansfromDecember2022toMay2024,weperformclinicaltrialsand
releasetheAI.vs.Cliniciandatabaseasthefirsthuman-AIinteractiondataadoptingSepsisdiagnosisforthefirststep. Onone
hand,Sepsisholdsimmensesignificanceinthefieldofmedicine. Itaffectsmillionsofpeopleworldwideandisaleading
causeofmorbidityandmortality12,13. UnderstandingthecomplexmechanismsunderlyingSepsisiscrucialforearlydetection,
accuratediagnosis,andeffectivetreatmentstrategies. Ontheotherhand,suchanalysisisalsoapplicableandvaluablefor
interactionanalysisinothermedicalissues.
AI.vs.Clinicianisanextensiveandhuman-centereddatabasethatcomprisesinformationrelatedtothebehaviorvariations
ofclinicians’diagnoseswithorwithouttheassistanceofdifferentAImodels. Thedatabasecontainsthedatarecordsofpatient
cohorts,AImodels,andclinicians. Intermsofpatientcohort,thedatabasecontains3000patientcaseswithcurrentandhistory
examinationdatatobediagnosedbyAImodelsandclinicians. FromtheperspectiveofAImodels,thedatabaseprovides
fourmodelswithdifferentmodeltypes(i.e.,traditionalmachinelearning,deeplearning)andproperties(i.e.,qualitytype,
qualitynumber),featureinputfortraining,andtheirinferenceresultsoneverypatientcaseincludingprobabilitiesofsepsis
onsetpresentlyandwithinnextthreehour. Asacontrol,wealsointroducearandommodelinourclinicalsettings. Notethat
the3-hourwindowalignswiththetreatmentguidelinesfromtheCMSsepsiscoremeasure(SEP1)andtheSurvivingSepsis
Campaign14–16. Theclinician-relatedinformationrecordsalltheiroperationsandcorrespondingtimestampsforpreliminary
diagnosisandtreatmentandfinaldiagnosisandtreatment.
WeexpectthatAI.vs.Clinicianwillhavebroadinternationalusageinvariousdomains,includingacademicandindustrial
research,comprehensionofthecomplexinteraction,qualityimprovementofAImodels,andfurtherfacilitatetheadvancement
andpracticalimplementationinAIinmedicine.
Patient Cohort Creation Human Clinicians Deidentification
Examination Data 14 Medical Centers
Integrity Diagnosis HAI-Med
7500 Diagnosis Records
Demographic Diversity
125 Clinicians Patient Cohort AI Models
Missing Data Filling 10 Clinical Settings Patient_Case_Info Model_Property
Patient_Fundamental_Item Model_Dataset
Critical Care Data Fluid_Input CoxPHM_Feature
( MIMIC-III & Deduplication Prediction Auxiliary Fluid_Output LSTM_Feature
MIMIC-IV & Diagnosis Validation Complete_Blood_Count Model_Cohort_Infer
MIMIC-CXR-JPG &
MIMIC-IV-Note ) Patient Admission IDs for AI Models Pathogen_Blood
AI Training Medical_Imaging
2 State-of-the-art AI Arterial_Blood_Gas_Analysis
Training Data Training Algorithms Haemostatic_Function
High, Medium, Low Culture_Smear Human Clinicians
Validating Data Model Qualities Procalcitonin
SOFA Clinician_Info
Testing Data R (a Cn od nto rom l GM roo ud p)el D Mr eu dg i_ caH lHist io str oy ry_ChiefComplaint C Cl li in ni ic ci ia an n_ _C Dl ii ac gk n_ oB sie sh _a Tv ri eo ar tment
Clinical Trials Data Preparation Clinical Trials using AI Models Database Structure
Figure1. AI.vs.ClinicianDatabaseDevelopmentProcess. Thehuman-AIinteractiondataareacquiredfromtheclinical
trialsusingAImodelsin14medicalcenters. ApatientcohortiscreatedbasedontheMIMICdatabases17–20andusedforthe
collaborativedecision-makingofAImodelsandclinicians. Finally,thecollecteddataarevalidatedandde-identified. Tablesin
AI.vs.Clinicianareclassifiedintothreecategories: patientcohortthatrecordsthepatients’informationandexaminationdata;
AImodelsthatrecordtheAImodelrelatedinformationandinferenceresultsonpatientcohort,andcliniciansthatrecordthe
clinicianinformationandinteractionbehaviorswithAImodels.
Methods
Ethicsstatement. ThisresearchhasbeenapprovedbytheEthicsCommitteeofGuilinMedicalUniversity(ApprovalNo:
GLMC20221101). Theapprovalcoverscollectingclinicianbehavioraldata,includingdiagnosisdecisions,timeconsumption,
andallrelatedoperations,aswellasthereconstructionandsharingofthisdata. Informedconsenthasbeenobtainedfromthe
cliniciansinvolved. Inthisdatabase,allpersonallyidentifiableinformation,exceptfortheclinician’sgenderandage,hasbeen
2/11eitherremovedorregeneratedinaccordancewithU.S.HIPAAregulations. Moreover,thepatientdatausedinthisdatabaseare
derivedfromthepubliclyavailableMIMICdatabases17–20. Theauthorshaveobtainedpermissiontousethisdataset,andno
newethicalissuesareinvolved. Additionally,thedatasetisexclusivelyrestrictedforlegitimatescientificresearchpurposes.
DataCollectionandProcessing. AI.vs.ClinicianrepresentsacollaborativeeffortbetweenInstituteofComputingTechnology,
ChineseAcademyofScience(ICT,CAS),InternationalOpenBenchmarkCouncil(BenchCouncil),GuangxiNormalUniversity,
andfourteencriticalmedicalcenterslikeGuilinMedicalUniversityinChina. Throughthispartnership,thehumaninformation
andbehaviordataobtainedfrom125cliniciansinfourteenmedicalcentersundergoesarigorousprocessofdeidentificationand
subsequentavailabilitytoqualifiedresearcherswhohavemadecommitmentstothelawfuluseofthedataandnotattemptingto
identifytheindividualsorinstitutesanddisseminatethedata. AI.vs.Clinicianhasobtainedtheofficialethicalreviewfrom
GuilinMedicalUniversityandtheofficialapprovaltosharethedataunderaseriesofcommitments. Inaddition,thedatabase
hasobtainedinformedconsentfromalltheclinicianparticipants. Thepopulationanddemographicsofclinicianparticipantsare
showninTable 1,coveringabroadspectrumofreal-worldpopulation21. Pleasenoteweonlylistthecharacteristicsof121
clinicianssincetheotherfourdonotprovidevalidinformation.
Figure 1illustratesthecreationstepsofAI.vs.Cliniciandatabase,including(1)creationofapatientcohort,whichwillbe
diagnosedbycliniciansandpre-trainedAImodels,andthusplaypivotalrolesinunravelingtheinteractionbetweenthetwo
entities,(2)datadeduplicationforAItraining,(3)AImodeltrainingtothestate-of-the-artorstate-of-the-practicequality,(4)
AImodelinferenceonpatientcohort,(5)cliniciandiagnosisonpatientcohortwithorwithouttheassistanceofAImodels,(6)
datavalidation,and(7)deidentification.
Table1. ClinicianPopulationandDemographics.
Category Characteristics No.ofClinicians(%byunit)
Male 69(57%)
Gender
Female 52(43%)
age≤30 30(25%)
30<age≤40 49(40%)
Age
40<age≤50 35(29%)
50<age≤60 7(6%)
(0,5] 31(26%)
(5,10] 22(18%)
YearsofWorking (10,15] 21(17%)
(15,20] 29(24%)
>20 18(15%)
None(Duringresidencytraining) 20(17%)
Junior(Residentphysician) 15(12%)
ClassofPosition
Intermediate(Attendingphysician) 41(34%)
Senior(ChiefandAssociateChiefPhysician) 45(37%)
Grade-ATertiaryHospitalinChina 44(36%)
InstitutionLevel Grade-ASecondaryHospitalinChina 76(63%)
MedicalUniversity 1(1%)
EmergencyDepartment 32(26%)
IntensiveCareUnit(ICU) 44(36%)
InternalMedicine 16(13%)
SurgeryDepartment 6(5%)
Orthopedics 1(1%)
Pediatrics 5(4%)
Ophthalmology 1(1%)
Department
Gynaecology 6(5%)
TraditionalChineseMedicine 4(3%)
Gastroenterology 1(1%)
InfectiousDiseasesDepartment 1(1%)
RheumatologyandImmunologyDepartment 1(1%)
Neurology 2(2%)
AnesthesiaDepartment 1(1%)
Weuseopensourceandwidelyusedclinicaldatabases–MIMIC(MedicalInformationMartforIntensiveCare)forsepsis
detectionandprediction,includingMIMIC-III1.417,MIMIC-IV2.218,MIMIC-CXR-JPG2.0.019,andMIMIC-IV-Note2.220.
3/11Amongthem,TheMIMIC-IIIcontainsoverfortythousandpatientswhostayedincriticalcareunitsbetween2001and201222.
TheMIMIC-IVcoversallmedicalrecordsofpatientsadmittedtoanICUortheemergencydepartmentbetween2008and
201923, an updated version of MIMIC-III. MIMIC-CXR-JPG is an extensive publicly available database of labeled chest
radiographs19. MIMIC-IV-Notecontains331,794de-identifieddischargesummariesfrom145,915patientsand2,321,355
de-identifiedradiologyreportsfor237,427patients24.
(1)CreationofPatientCohort.
Weconstructapatientcohortthatcontainsaseriesofpatientcasesaccordingtothecriteriasetbyourcollaboratingclinicians,
simultaneouslyensuringdemographicdiversity. EachpatientcasecontainsapatientID(subject_idinthedataset),apatient
admissionID(hadm_idinthedataset),andacurrenttimeframe. Notethatthecurrenttimeframeassumesthemomentwhena
patientisbeingdiagnosed,whereboththeclinicianandthemodelcanonlyaccessthedatauntilthecurrenttimeandhave
novisibilityintofuturedata. Itcanencompassvariousstagesforsepsispatients,includingthepre-onset,onset,orpost-onset
periodsofSepsis,aswellasanarbitrarytimeframeduringhospitalstaysfornon-sepsispatients.
WeuseMIMIC-IV,MIMIC-CXR-JPG,andMIMIC-IV-Notetochoose3000patientcasescontainingmedicalimagingand
comprehensiveexaminationdata. Thepatientcasescontain1500positivecases(Sepsis)and1500negativeones(non-sepsis).
ThechoosingstepsareasfollowsandshowninFigure 2.
Single Out Sepsis Patients and Determine Onset Time
Antibiotic Sample collected
given for culture
within 24 hours Sepsis Patients
Adult Patients in MIMIC-IV with Onset Time
sepsis onset time
(age >= 18) Non-sepsis
Sample collected Antibiotic
Patients
for culture given
within 72 hours
sepsis onset time
Establish One-hour Time Window Candidates for Sepsis and Non-sepsis
Onset
Time window 3 hrs before onset Time window 3 hrs after onset
Sepsis Patients: window
1 hr 1 hr …… 1 hr ……
admission sepsis onset time
time
Non-sepsis Patients:
Time windows
1 hr 1 hr ……
admission 4 hrs after Discharge or 14 days
time admission after admission
Patient Cohort Creation
All time
Missing data data integrity
window diversity checking
filling checking
candidates
Well-chosen time windows indicating sepsis or non-sepsis patients with a current time frame
Figure2. PatientCohortCreation.
• For all adult (age≥18) patients in MIMIC-IV dataset, we determine the onset time of Sepsis referring to the third
4/11internationalconsensusdefinitionsforSepsis(Sepsis-3)15,25 andresearchespublishedonNatureMedicine26,27 and
JAMA28.Duringapatient’shospitalstay,ifhe/shehadqSOFAandSOFAscores29greaterthanorequalto2,wefurther
checkwhetherhe/shewasgivenantibioticsandcollectedsamplesformicrobiologicalculture. Iftheantibioticwasgiven
firstandthemicrobiologicalsamplewascollectedwithin24hours,thenthegiventimeofantibioticwastheonsettimeof
Sepsis. Ifthesampleformicrobiologicalculturewascollectedfirstandtheantibioticwasgivenwithin72hours,thenthe
microbiologicalsamplecollectiontimeistheonsettime. TheotherpatientswithqSOFAandSOFAscoresoflessthan
twoareconsideredpatientswithoutSepsis(non-sepsis).
• ForthepatientswithSepsis,westartfromtheiradmissiontimeandslideusingaone-hourwindowuntilwecoverthe
threehoursaftertheonsetofSepsis. Fromaseriesofone-hourwindows,weselecttimewindowsthatfullycoverthe
threehours,twohours, oronehourbeforetheonsettimeofSepsis. Wealsoincludethetimewindowthatcontains
theonsetofSepsisitself. Additionally,wechoosetimewindowsthatentirelycovertheonehour,twohours,orthree
hoursaftertheonsetofSepsis. Thus,apatientcanhaveamaximumofseventimewindowsbeenselected. Then,for
theselectedtimewindows,wefurthercheckwhethertheexaminationdatawithinthatperiodarecompleteandsingle
outthetimewindowsthatcontainallsevenfundamentalitemsandatleastfouradvanceditemsaspositivepatientcase
candidates. Notethatbeforetheintegritycheck,weemployedthemissingdatafillingrulesreferringto30,31forallthe
examinationitems,consideringwhetheradverseeventsoccurredandthevalidityperiod. Thesevenfundamentalitems
arebodytemperature,systolicbloodpressure,diastolicbloodpressure,heartrate,respiratoryrate,consciousnesslevel,
and24-hourfluidinput/output. Therespiratoryrate,consciousnesslevel,andsystolicbloodpressureinfundamental
itemsareusedtocalculateqSOFAscore15. Thesevenadvanceditemsarecompletebloodcount,arterialbloodgas
analysis,hemostaticfunction,medicalimagingdata,pathogenscreening,cultureanalysis,andsmeartests. Afterthat,we
singleout8639positivecandidates.
• ForeachpatientwithoutSepsis(non-sepsis),westartfromfourhoursafteradmissiontoavoidleakageduetoashorttime
rangeanditeratebythehouruntilthetimeofdischargeor14daysafteradmission. Duringthisperiod,weidentifyand
selectallone-hourtimewindowsthatcontainallsevenfundamentalitemsandatleastfouradvanceditemsasnegative
patientcasecandidates. Thetotalnumberis3832.
• Wechoose1500positivecasesand1500negativecasesconsideringthedemographicdiversity,includingage,gender,
andweight. Forpositivecases,wealsoconsiderbalancingtheproportionofcasesforthethree-hourperiodbeforeonset,
thetimeofonset,andthethree-hourperiodafteronset. Notethatthetotal3000casesarefrom2800non-repetitive
patients. For100outofthe2800patients,wechoosethreetimeperiods: before,during,andaftertheonset. Fortheother
2700patients,weonlyincludeonetimeperiodthatiseitherbefore,during,oraftertheonset. Finally,weclassifythese
patientcasesintofivegroups,eachcontaining300positivecasesand300negativecaseswithsimilarcharacteristicsand
distribution.
Table 2showsthepatientcohortpopulationanddemographics.
(2)DataDeduplicationforAITraining.
Fordataleakageprevention,weremoveallpatientsselectedascasesfromtheMIMICdatasetsanddividetheremainingpatient
admissionIDs(hadm_id)intotraining,validating,andtestingsetsforAItraining. Wefirstperformdatadeduplicationby
removingallthepatientdatathathavealreadybeenchosenaspatientcasesfromMIMIC-IIIandMIMIC-IVtousethesetwo
databasesforjointtraining. Afterthat,weobtainthreesets,eachcontainingasetofpatientadmissionIDsthatwillbeused
astraining,validating,ortestingdatainthefollowingstep,withaproportionof7:1:2. Weestablish10528non-repetitive
patientadmissionIDsandpartitionthemrandomlyintotraining,validating,andtestingsets,withthenumbers7376,1030,and
2122,respectively. Detailedly,thetrainingsetcontains3395positivepatientadmissionIDs(1732fromMIMIC-IIIand1663
fromMIMIC-IV)and3981negativepatientadmissionIDs(676fromMIMIC-IIIand3305fromMIMIC-IV).Thevalidating
setcontains464positivepatientadmissionIDs(227fromMIMIC-IIIand237fromMIMIC-IV)and566negativepatient
admissionIDs(95fromMIMIC-IIIand471fromMIMIC-IV).Thetestingsetcontains1012positivepatientadmissionIDs
(537fromMIMIC-IIIand475fromMIMIC-IV)and1110negativepatientadmissionIDs(167fromMIMIC-IIIand943from
MIMIC-IV).
(3)AIModelTraining.
Wefurtherinvestigatethestate-of-the-artorstate-of-the-practiceAIalgorithmsforsepsisdetectionandpredictiontoexplore
theinteractionbetweenAIandclinicians. Coxproportionalhazardsmodel(CoxPHM)14,32,33 andlongshort-termmemory
(LSTM)34 arerepresentativemodelsfromsurvivalanalysisanddeeplearning35,respectively,andarethetwomostpopular
andwidelyusedAIalgorithmsforsepsisdetectionandprediction. Wechoosefeaturesfromthepatient’sexaminationdata
5/11Table2. PatientPopulationandDemographicsofPatientCohort.
No.ofPatients(%byunit)
Category Characteristics
All Group1 Group2 Group3 Group4 Group5
Sepsis 1500(50%) 300 300 300 300 300
Issepsis?
Non-sepsis 1500(50%) 300 300 300 300 300
Atonset 1000(33%) 200 200 200 200 200
Currenttimefor
3hoursbeforeonset 250(8%) 50 50 50 50 50
sepsispatients
3hoursafteronset 250(8%) 50 50 50 50 50
Male 1704(57%) 332 344 339 352 337
Gender
Female 1296(43%) 268 256 261 248 263
18≤age≤30 128(4%) 22 30 31 26 19
31≤age≤40 128(4%) 18 25 24 31 30
41≤age≤50 285(10%) 55 65 65 53 47
Age 51≤age≤60 552(18%) 106 111 113 116 106
61≤age≤70 682(23%) 144 125 145 127 141
71≤age≤80 638(21%) 147 122 119 124 126
age>80 587(20%) 108 122 103 123 131
Weight<40 17(1%) 2 5 3 4 3
41≤Weight≤50 110(4%) 29 21 15 19 26
51≤Weight≤60 326(11%) 72 80 54 63 57
61≤Weight≤70 549(18%) 107 124 112 103 103
Weight(kg)
71≤Weight≤80 564(19%) 114 109 115 114 112
81≤Weight≤90 508(17%) 106 89 116 98 99
91≤Weight≤100 349(11%) 62 76 67 76 68
Weight>100 577(19%) 108 96 118 123 132
0 756(25%) 130 145 149 182 150
1 1435(48%) 298 269 281 281 306
QSOFAScore
2 707(24%) 142 165 157 117 126
3 102(3%) 30 21 13 20 18
Within 90 days for
Mortality 13.27% 13.67% 15% 11.33% 15.33% 11%
sepsispatients
accordingto14,32,33foraCoxPHMmodeland34foranLSTMmodel,respectively,andfurtherimplementdetectionversions
andpredictionversionsofthesetwomodelswithdifferentmodelqualities. Amongthem,thedetectionversionoutputsthe
probabilityofthesepsisonsetatpresent,andweuse0htorepresentthistype. Thepredictionversionoutputstheprobabilityof
thesepsisonsetwithinthenextthreehours,andweuse3htorepresentthistype. Thedetectionandpredictionversionsfortwo
modelswithAUC(areaunderthecurve)0. XXiscalledLSTM-0h-AUCXX,andLSTM-3h-AUCXXforshort. Forexample,
LSTM-0h-AUC95meanstraininganLSTMmodelwithAUC0.95todetectwhetherapatientisinsepsisonset. CoxPHM-0h
andCoxPHM-3haretwomodelswithAUC0.95. ThedetailsareshowninFig.3.
• LSTM Model Features and Labels. For LSTM models, We organize 336 (14 days * 24 hours/day) lines of patient
examinationdataasatraining,validating,ortestingsample. Startingfromthepatient’sadmissiontime,eachlinecontains
theexaminationdatawithinonehouruntiltheendconditionorreaching14days. Ifthenumberoflinesislessthan336,
theremaininglinesarefilledwiththevalueof-4. ForLSTM-0h,thepositivesamplesconsistoftwoparts: patientswho
areinthesepsisonsetphaseandpatientswhohavebeenexperiencingSepsisforthreehours. Fortheformerpart,we
startfromtheiradmissiontimeandslideusingaone-hourwindowuntilwecovertheonsettimeofSepsis. Forthelatter
part,wealsostartfromtheiradmissiontimeandslideusingaone-hourwindowuntilwecoverthethreehoursafterthe
onsetofSepsis. Whentherearemissingexaminationitems,priorityisgiventosupplementingthemwithadjacentdata
fromthesamepatientwithinthevalidperiod,providedthatnoadverseeventshaveoccurred. Ifthisconditionisnot
met,themissingitemsaresupplementedwiththeaveragevaluesofthecorrespondingdataitemsfromallpatientsatthe
sametimeintervalfromtheonsetofSepsis. Thenegativesamplesalsocontaintwoparts: non-sepsispatientsandsepsis
patientsmorethan12hoursawayfromtheonsettime. Sincenon-sepsispatientshavenoonsettime,theendcondition
isbasedonaGaussiandistributionofthelengthofthehospitalstayforsepsispatientstoavoidmodelleakage. For
LSTM-3h,thepositiveandnegativesamplesadoptthesamestrategyasLSTM-0h. ThedifferenceisthattheLSTM-3h
addsthepatientswhowillexperiencesepsisonsetwithinthenextthreehoursasthepositivesamples.
• CoxPHMModelFeaturesandLabels. ContrarytotheLSTMmodelsthatstartfromtheadmissiontime,theCoxPHM
6/11modelsstartfromthesepsisonsettimeandslidebackwardtowardtheadmissiontimeusingaone-hourwindow.
• HyperparameterSettings. Thehyperparametersettingsareasfollows. LSTM-0h-AUC95andLSTM-3h-AUC95: using
batchsize32,learningrate0.0001,andconvergencetraining. LSTM-0h-AUC85: usingbatchsize32,learningrate0.003,
andtrainingonlythreeepochs. LSTM-0h-AUC75: usingbatchsize32,learningrate0.007,andtrainingonlytwoepochs.
LSTM-3h-AUC85:usingbatchsize32,learningrate0.005,andtrainingthreeepochs. LSTM-3h-AUC75: usingbatchsize
32,learningrate0.00715,andtrainingtwoepochs. CoxPHM-0h: l1_ratio1,penalizer0.05,step_size0.1,precision
1e-08,andmax_steps1000.
• ModelQuality. Ourtrainedmodelshaveachievedstate-of-the-artmodelqualitycomparabletotheresultsreportedin
relevantresearch. TheAUContestingdataforLSTMachieves0.95. Inaddition, inordertoexploretheimpactof
modelqualityonhumandecision,wefurthertraintwoLSTMmodelswithamediumquality(AUC85)andalowquality
(AUC75). Specifically, theAUCsforLSTM-0h-AUC95, LSTM-0h-AUC85, LSTM-0h-AUC75, LSTM-3h-AUC95,
LSTM-3h-AUC85,andLSTM-3h-AUC75are0.9468,0.8497,0.7447,0.9565,0.8506,and0.7565,respectively. The
AUCsontestingdataforCoxPHM-0handCoxPHM-3hare0.95and0.92,respectively.
MIMIC Datasets Feature Selection
Training Set
LSTM Features
Validating Set
Test Set CoxPHM Features
Model Training Data Filtering
LSTM (High-quality) MIMIC-III:
data missing rates < 40%
Attention
BiLSTM 256 MIMIC-IV:
BiLSTM 128 non-empty fundamental
BiLSTM 64 items = 7
non-empty advanced
LSTM (Medium-quality) items >= 4
Detection
Attention
(0h)
BiLSTM 256
Reference Table for
Prediction
LSTM (Low-quality) Missing Data Filling
(3h)
Attention Hourly average values of
BiLSTM 256 sepsis patients
Hourly average values of
CoxPHM non-septic patients (dead)
Hourly average values of
non-septic patients (alive)
Inference Models
LSTM-0h-AUC95 LSTM-0h-AUC85 LSTM-0h-AUC75
LSTM-3h-AUC95 LSTM-3h-AUC85 LSTM-3h-AUC75
CoxPHM-0h CoxPHM-3h
Figure3. TheDetailedTrainingProcessforLSTMandCoxPHM.
(4)AIModelInferenceonPatientCohort.
Weusethetrainedmodelstopredicteverypatientcasewithinthewell-chosenpatientcohort. Wecollectthecorresponding
featuresrequiredbythemodelsforallthepatientcases. Notethattheendtimeisthecurrenttimeframespecifiedineachpatient
casetoensurethelatterinformationisinaccessibleforboththecliniciansandAImodels. Themodelqualityofthepatientcases
isasfollows: TheAUCsforLSTM-0h-AUC95,LSTM-0h-AUC85,LSTM-0h-AUC75,LSTM-3h-AUC95,LSTM-3h-AUC85,
andLSTM-3h-AUC75are0.9974,0.9808,0.8088,0.9999,0.9854,and0.8325,respectively. TheAUCsforCoxPHM-0hand
CoxPHM-3hare0.92and0.98,respectively.
(5)ClinicalTrialsusingAIModels.
Inthisstep,weperformclinicaltrialsusingAImodelsinourcollaborativemedicalcenters. Theclinicianswilldiagnosethe
patientcaseswithinthewell-chosenpatientcohortwithorwithouttheassistanceofdifferentAImodels. Webuildaspecialized
onlinediagnosissystemforclinicians’diagnosesandtreatments,recordingalltheiroperationsandtimestamps,includingthe
7/11login,logout,diagnosis,treatment,clickedexaminationitems,andallcorrespondingtimestamps. Notethatforeachpatient
case,theclinicianfirstperformspreliminarydiagnosisaccordingtothecurrentfundamentalexaminationdataandallthehistory
examinationdatawithorwithouttheprobabilityoutputofAImodels. Afterthepreliminarydecision,thecliniciancanclickon
thecurrentadvancedexaminationdataformoreinformationandmakeafinaldecision. Theclinicianscanchoosefromfive
options,severeSepsis,Sepsis,highsuspicion,lowsuspicion,andnon-sepsis,tomakeapreliminaryorfinaldecision,orthey
canenterthetextintheinputboxdirectly. Inaddition,theycanprovidetreatmentanddrugregimensthroughatextboxafter
thepreliminaryandfinaldiagnosis. Allthehuman-AIinteractiondataarerecordedinthisspecializedsystem.
(6)DataValidation.
Wevalidateandsingleouteffectivedataaccordingtothefollowingcriteria:
• Theclinician’sinformationiscomplete.
• Thediagnosisprocessesarecomplete,includingboththepreliminaryandfinalstages.
• Thetimestampofthefinaldiagnosisismorethanthatofthepreliminarystage.
• Atleastonediagnosisconclusionofthepreliminaryorfinalstageexplicitlyindicatesasepsis-relateddiagnosticdecision.
(7)Deidentification.
FollowingthestipulationsandidentifiersdefinedbyTheHealthInsurancePortabilityandAccountabilityAct(HIPAA),we
removeallthesensitiveidentifierstode-identifytheclinician’sinformation,includingthename,location,nationalidentification
number,phonenumber,emailaddress,andinstitution. WealsorandomizetheIDnumberinourdatabasesothattheclinicians
fromthesameinstitutionwillbeshuffled. Additionally,foreachclinician,timestampsareshiftedintothefuturewitharandom
offset,andthisshiftisdoneconsistentlytoensurethatthebehaviorintervalswithinthesameclinicianremainpreserved.
Data Records
WeadoptaconsistentorsimilarschemeforourdatabaseconstructiontobecompatiblewithMIMICdatabases. AI.vs.Clinician
adopts a relational type and contains 22 tables. Partial identifiers used for the tables are the same as the MIMIC-III and
MIMIC-IVdatabases,forexample,subject_idandhadm_id,sothattheuserscandirectlylocatethecorrespondingpatientin
theMIMICdatabases.
AI.vs.Clinicianprovidesthepatientrelated,AImodelrelated,andclinicianrelatedtables. Intermsofthepatientcohort,the
databaseprovides14tables,includingthepatientcaseinformation,thecurrentandhistoryfundamentalexaminationitems,the
currentandhistoryadvancedexaminationitems,SOFA,drughistory,medicalhistory,andchiefcomplaint. Thesedataare
eitherreorganizedoranalyzedbasedontheMIMICdatabasesandthecreationcriteriaofthepatientcohort. RegardingAI
models,thedatabaseprovidesfivetables,includingthemodelpropertieslikeModel_ID,Model_Name,sensitivity,specificity,
precision,AUC(areaunderthecurve),etc.,themodeldatasetsusedfortraining,validating,andtesting,theinputfeatures
usedbythemodels,andtheinferenceresultsonthepatientcohort. Withrespecttoclinicians,thedatabaseprovidesthree
tables,includingtheclinician’sinformationlikeClinician_ID,Insitution_Level,gender,etc.,theclinician’sclickbehaviorslike
clickingandviewinganexaminationitem,andtheclinician’spreliminaryandfinaldiagnosisdecisionsandtreatmentona
patientcasewithorwithouttheaidofanAImodel. Thedetailsaboutthe22tablesarelistedinTable 3.
Technical Validation
The construction process of the AI.vs.Clinician database underwent a series of procedural and manual validations and
assessments,rigorouslyaddressingaspectssuchascorrectness,integrity,consistency,deidentification,andethics. Version
controlsoftwarewasutilizedforcodemanagement,whileallthedataprocessingortransformationoperationswereperformed
usingareproduciblescript.
Inprocessingpatientdata,westrictlyadheretotherequirementsandspecificationsoftheMIMICdatabase,conducting
thoroughdataverificationandvalidation. Forinstance,whenusingMIMIC-IIIandMIMIC-IV,astheirperiodsoverlapand
maycontainduplicatepatients, werigorouslyscreenanddeduplicatethedatatopreventissuesofdataleakageduringAI
modeltraining. Weselectstate-of-the-artorstate-of-the-practicealgorithmsforAImodelsandensurethatthemodelachieves
comparableperformancetothereferencepapers. Inthediagnosticphasewithclinicians,weconstructanonlinediagnosis
systemandconfirmthecorrectnessandcompletenessofthedatathroughextensivediscussionswithnumerousclinicians. We
strictlyadheretotherulesofclinicaltrialsinselectingparticipatingclinicians,settingcontrolgroups,andconductingmultiple
roundsofsystemusagetraining. Withconsent,allactionsarerecordedbytheonlinesystem. Weverifythecompletenessand
8/11Table3. OverviewofTablesinAI.vs.ClinicianDatabase.
TableName Description
Patient_Case_Info Theinformationforeachpatientcase,includingtheidentifierinformation,demographics,
admissiontime,Sepsisornon-sepsis,sepsisonsettime,andcurrenttimewindow.
Patient_Fundamental_Item Thecurrentandhistoryinformationofsevenfundamentalexaminationitemsforpatientcases.
Fluid_Input Thelatest24-hourandhistoryfluidinputinformationforeachpatientcase.
Fluid_Output Thelatest24-hourandhistoryfluidoutputinformationforeachpatientcase.
Complete_Blood_Count Thecurrentandhistorycompletebloodcountinformationforeachpatientcase.
Pathogen_Blood Thecurrentandhistorypathogenbloodinformationforeachpatientcase.
Medical_Imaging Thecurrentandhistorymedicalimaginginformationforeachpatientcase.
Arterial_Blood_Gas_Analysis Thecurrentandhistoryarterialbloodgasanalysisdataforeachpatientcase.
HemostaticFunction Thecurrentandhistoryhemostaticdataforeachpatientcase.
Culture_Smear Thecurrentandhistoryculturesmearinformationforeachpatientcase.
Procalcitonin Thecurrentandhistoryprocalcitonininformationforeachpatientcase.
SOFA ThecurrentvariablesofsixtypesrelatedtothecomputationofSOFAscore,referringto15,25,28
foreachpatientcase.
Drug_History Thedrughistoryinformationforeachpatientcase.
MedicalHistory_ChiefComplaint Themedicalhistoryandchiefcomplaintinformationforeachpatientcase.
Model_Property The properties of each AI model, including the model ID, model name, the sensitivity,
specificity,precision,andAUContraining,validating,andtestingdataset.
Model_Dataset ThepatientadmissionIDs(hadm_id)usedasthetrainingset,validatingset,ortestingsetfor
alltheAImodels.
CoxPHM_Feature ThefeatureinputforeachpatientcasetotrainaCoxPHMmodel.
LSTM_Feature ThefeatureinputforeachpatientcasetotrainanLSTMmodel.
Model_Cohort_Infer TheinferenceresultsoffourAImodelsandonerandommodelonthepatientcohort,including
thedecision,theprobabilityofsepsisonsetpresently(0h),andtheprobabilityofsepsisonset
withinthenextthreehours(3h).
Clinician_Info Theinformationforeachclinician,includingtheidentifierinformation,demographics,depart-
ment,yearsofworking,classofposition,andareaofexpertise.
Clinician_Click_Behavior Theinformationofclinician’sclickbehaviors,includingtheclickedexaminationitemfor
viewing,andtheclickedtime.
Clinician_Diagnosis_Treatment Each clinician’s preliminary and final diagnosis decisions and treatment on each patient
case with or without the aid of an AI model, including the clicked sequence (link with
Clinician_Click_Behaviortable),preliminarydecision,finaldecision,preliminarytreatment,
finaltreatment,andcorrespondingtimestamps.
correctnessofthedatathroughproceduresandmanually,suchasexcludingdatawherediagnosesareincompleteorirrelevant,
toensuretherationalityofthedata.
Basedonalltherecordsandlogsfromtheonlinesystem,theAI.vs.Cliniciandatabaseisconstructedthroughaseriesof
processes,includingintegritychecks,consistencychecks,anddeidentificationchecks. Specifically,wecreateasetofrulesand
unitteststocheckallthetableswithinthedatabase.
Usage Notes
DataAccess. AI.vs.Cliniciandatabasecomprisesasetofcomma-separatedvalue(CSV)filesandallrelatedsourcecode. Since
thedatabasecontainsnotonlythepatients’informationfromMIMICdatabasesbutalsotheclinicians’informationfrom14
medicalcenters,usersmustusethedatabasewithcautionandrespect. ThedatabasehasbeenuploadedtoPhysioNet36platform
andiswaitingforapproval. Toaccessthedatabase,thefollowingstepsneedtobecompleted:
• TheresearchersmustcompletetheaccessstepsrequiredbyMIMICdatabases.
• Theresearchersarerequiredtosignadatauseagreement,whichdelineatesacceptabledatausageandsecurityprotocols
andprohibitsattemptstoidentifyindividualcliniciansandpatients.
• Theresearchersarerequiredtosendanaccessrequesttothecontributorsandprovideadescriptionoftheresearchproject.
Example Usage. AI.vs.Clinician provides the first database for the research on human and AI interaction, which holds
significantimportancefordevelopingAIinmedicineandtranslatingAIintoclinicalpractice. AI.vs.Clinicianfacilitatesa
9/11widearrayofresearchinvestigations,suchasAIalgorithmbenchmarking,optimization,andhuman-in-the-loopresearchin
medicine.
AI.vs.Clinicianprovidesacollectionofsourcecodesusedduringitsconstruction,e.g.,thecreationofpatientcohort,data
deduplication,AImodeltrainingandinference,datavalidation,etc.,aswellastherelatedcodeforprocessingandanalysis.
TheinstructionsforusingthedatabaseareillustratedinaREADMEfileinthedatabasepackage. Wewillfurtherexpandthe
datasetandprovidemorecomprehensivescripts.
Code availability
SinceAI.vs.CliniciandatabaseisbasedonMIMICdatabase,theusersarerequiredtobeacredentialeduserofMIMICand
completetherequiredtraining. Duetothesensitiveclinicianinformation,thefulldiagnosisrecordsandlogscannotbepublicly
released.However,besidesthereorganizeddatabaseillustratedinthispaper,wealsoprovideanoriginalversion,whichhasbeen
performedinthesameprocessofvalidationanddeidentification. Thedifferencesarethattheoriginalversionusestheoriginal
tablestructuresfromtheonlinediagnosissystemandprovidesbothEnglishandChineseinformation. Afteridentification,the
databaseispubliclyavailablefromPhysioNet(awaitingapproval). Allthesourcecodeforcreatingpatientcohort,AItraining
andinference,etc.,isavailablefromhttps://github.com/BenchCouncil/AI.vs.Clinician.
References
1. Holmes,J.,Sacchi,L.,Bellazzi,R.&Peek,N. Artificialintelligenceinmedicine. AnnRCollSurgEngl86,334–8(2004).
2. Rajpurkar,P.,Chen,E.,Banerjee,O.&Topol,E.J. Aiinhealthandmedicine. Nat.medicine28,31–38(2022).
3. Hamet,P.&Tremblay,J. Artificialintelligenceinmedicine. Metabolism69,S36–S40(2017).
4. Topol,E.J. High-performancemedicine: theconvergenceofhumanandartificialintelligence. Nat.medicine25,44–56
(2019).
5. He,J.etal. Thepracticalimplementationofartificialintelligencetechnologiesinmedicine. Nat.medicine25,30–36
(2019).
6. Yun,J.H.,Lee,E.-J.&Kim,D.H. Behavioralandneuralevidenceonconsumerresponsestohumandoctorsandmedical
artificialintelligence. Psychol.&Mark.38,610–625(2021).
7. Cohen,I.G.etal. Howaicanlearnfromthelaw: puttinghumansinthelooponlyonappeal. npjDigit.Medicine6,160
(2023).
8. Patel,B.N.etal. Human–machinepartnershipwithartificialintelligenceforchestradiographdiagnosis. NPJdigital
medicine2,111(2019).
9. Fosch-Villaronga,E.,Khanna,P.,Drukarch,H.&Custers,B.H. Ahumanintheloopinsurgeryautomation. Nat.Mach.
Intell.3,368–369(2021).
10. Yu,R.etal. Pi-radsai: introducinganewhuman-in-the-loopaimodelforprostatecancerdiagnosisbasedonmri. Br.J.
Cancer128,1019–1029(2023).
11. Walsh,C. Human-in-the-loopdevelopmentofsoftwearablerobots. Nat.Rev.Mater.3,78–80(2018).
12. Mayr,F.B.,Yende,S.&Angus,D.C. Epidemiologyofseveresepsis. Virulence5,4–11(2014).
13. Rudd,K.E.etal. Global,regional,andnationalsepsisincidenceandmortality,1990–2017: analysisfortheglobalburden
ofdiseasestudy. TheLancet395,200–211(2020).
14. Henry,K.E.etal. Factorsdrivingprovideradoptionofthetrewsmachinelearning-basedearlywarningsystemandits
effectsonsepsistreatmenttiming. Nat.medicine28,1447–1454(2022).
15. Singer,M.etal. Thethirdinternationalconsensusdefinitionsforsepsisandsepticshock(sepsis-3). Jama315,801–810
(2016).
16. Levy,M.M.,Evans,L.E.&Rhodes,A. Thesurvivingsepsiscampaignbundle: 2018update. Intensivecaremedicine44,
925–928(2018).
17. Johnson,A.E.etal. Mimic-iii,afreelyaccessiblecriticalcaredatabase. Sci.data3,1–9(2016).
18. Johnson,A.E.etal. Mimic-iv. PhysioNet.Availableonlineat:https://physionet.org/content/mimiciv/1.0/(accessedAugust
23,2021)(2020).
19. Johnson, A.E. et al. Mimic-cxr-jpg, a large publicly available database of labeledchest radiographs. arXiv preprint
arXiv:1901.07042(2019).
10/1120. Johnson,A.,Pollard,T.,Horng,S.,Celi,L.A.&Mark,R. Mimic-iv-note: Deidentifiedfree-textclinicalnotes(2023).
21. Zhan,J.etal. Evaluatology: Thescienceandengineeringofevaluation. BenchCouncilTransactionsonBenchmarks,
StandardsEval.4,100162(2024).
22. Mimic-iiiweb. https://physionet.org/content/mimiciii/1.4/.
23. Mimic-ivweb. https://physionet.org/content/mimiciv/2.2/.
24. Mimic-iv-note. https://physionet.org/content/mimic-iv-note/2.2/.
25. Yu,X.etal. Guidelinesforemergencytreatmentofsepsisandsepticshock(2018). J.Clin.Emerg.(China)38,741–756
(2018).
26. Komorowski,M.,Celi,L.A.,Badawi,O.,Gordon,A.C.&Faisal,A.A. Theartificialintelligenceclinicianlearnsoptimal
treatmentstrategiesforsepsisinintensivecare. Nat.medicine24,1716–1720(2018).
27. Thecodetodetecttheonsettimeofsepsis. https://github.com/cmudig/AI-Clinician-MIMICIV?tab=readme-ov-file.
28. Seymour,C.W.etal. Assessmentofclinicalcriteriaforsepsis: forthethirdinternationalconsensusdefinitionsforsepsis
andsepticshock(sepsis-3). Jama315,762–774(2016).
29. Lambden,S.,Laterre,P.F.,Levy,M.M.&Francois,B. Thesofascore—development,utilityandchallengesofaccurate
assessmentinclinicaltrials. CriticalCare23,1–9(2019).
30. Jain,M.,Miller,L.,Belt,D.,King,D.&Berwick,D. Declineinicuadverseevents,nosocomialinfectionsandcostthrough
aqualityimprovementinitiativefocusingonteamworkandculturechange. Qual.&safetyhealthcare15,235(2006).
31. Mao,Q.etal.Multicentrevalidationofasepsispredictionalgorithmusingonlyvitalsigndataintheemergencydepartment,
generalwardandicu. BMJopen8,e017833(2018).
32. Henry,K.E.,Hager,D.N.,Pronovost,P.J.&Saria,S. Atargetedreal-timeearlywarningscore(trewscore)forseptic
shock. Sci.translationalmedicine7,299ra122–299ra122(2015).
33. Adams,R.etal.Prospective,multi-sitestudyofpatientoutcomesafterimplementationofthetrewsmachinelearning-based
earlywarningsystemforsepsis. Nat.medicine28,1455–1460(2022).
34. Kaji,D.A.etal.Anattentionbaseddeeplearningmodelofclinicaleventsintheintensivecareunit.PloSone14,e0211057
(2019).
35. Cohen,S.N.etal. Subtlevariationinsepsis-iiidefinitionsmarkedlyinfluencespredictiveperformancewithinandacross
methods. Sci.Reports14,1920(2024).
36. Goldberger,A.L.etal. Physiobank,physiotoolkit,andphysionet: componentsofanewresearchresourceforcomplex
physiologicsignals. circulation101,e215–e220(2000).
Acknowledgements
WeacknowledgesupportsfromtheInnovationFundingofICT,CASunderGrantNo. E461070. Wethankalltheparticipating
medicalcentersandclinicians.
Author contributions statement
W.G.conceptualizedthisstudy,conceivedtheexperiments,implementedtheCoxPHMmodelaccordingtothereferencedpaper,
andwrotethemanuscript. Y.L.conceptualizedthisstudyanddefinedthepatientcohortcriteria. Z.Y.,D.C.,W.L.,X,L.,J.Z.,
J.X.,andH.L.implementedtheLSTMmodelsandonlinediagnosissystemandcollectedandanalyzedthedata. L.M.,N.Y.,
Y.K.,D.L.,P.P.,W.H.,Z.L.,J.H.,F.H.,G.Z.,andC.J.recruitedcliniciansandparticipatedintheexperiment. Z.Z.,Y.H.,and
J.Z.conceptualizedthisstudy,directedtheproject,andrevisedthemanuscript. Allauthorshavereadandapprovedthefinal
manuscript.
Competing interests
Theauthorsdeclarenocompetinginterests.
11/11